Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic effects of rolofylline in hospitalized patients with acute heart failure and renal impairment
2008-002209-38Phase 2Terminated
- Sponsor
- NovaCardia
- Start
- Jun 2008
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Acute Heart Failure (AHF) comparing Rolofylline plus loop diuretic therapy with Placebo plus loop diuretic therapy (2 arms). Primary endpoints: Change in pulmonary capillary wedge pressure at 4 hours and Change in pulmonary capillary wedge pressure at 8 hours. Started Jun 2008; status: terminated.
02
Drugs
rolofylline
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2008-002209-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002209-38.